Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease gastric cancer
Phenotype C0948303|peritoneal carcinoma
Sentences 26
PubMedID- 20544347 Predictive factors for improving survival after gastrectomy in gastric cancer patients with peritoneal carcinomatosis.
PubMedID- 19688824 Previously, we showed elevated mrna levels of phosphoglycerate kinase 1 (pgk1), an adenosine triphosphate-generating enzyme in the glycolytic pathway, the chemokine receptor 4 (cxcr4), the corresponding chemokine ligand 12 (cxcl12) and beta-catenin in specimens from gastric cancer patients with peritoneal carcinomatosis.
PubMedID- 21548973 Background: cytoreductive surgery (crs) plus hyperthermic intraperitoneal chemotherapy (hipec) has been considered as a promising treatment modality for gastric cancer with peritoneal carcinomatosis (pc).
PubMedID- 20082194 Background: the aim of this study was to review prognosis following gastrectomy for gastric cancer patients with synchronous peritoneal carcinomatosis and to identify predictive factors for improving survival after gastrectomy in this setting.
PubMedID- 21713780 Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and hipec: a systematic review of survival, mortality, and morbidity.
PubMedID- 23467441 gastric cancer with peritoneal carcinomatosis (pc) has a poor prognosis.
PubMedID- 22615966 Therefore, the frequency of gastric cancer with microscopic peritoneal carcinomatosis might be higher than the suggested.
PubMedID- 23185152 Diffuse gastric cancer with peritoneal carcinomatosis can mimic crohn's disease.
PubMedID- 24157224 Background: the aims of this study were to create a model of peritoneal carcinomatosis in patients with gastric cancer and to evaluates outcomes in patients with gastric cancer treated using surgery and hyperthermic intraperitoneal chemotherapy (hipec).
PubMedID- 20401915 Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: results from a chinese center.
PubMedID- 22898806 Background: few studies of systemic chemotherapy have focused on gastric cancer with peritoneal carcinomatosis (pc) without measurable lesions.
PubMedID- 23423490 Phase i/ii study of intraperitoneal docetaxel plus s-1 for the gastric cancer patients with peritoneal carcinomatosis.
PubMedID- 23895276 In recent years, the improved survival associated with hyperthermic intraperitoneal perfusion chemotherapy for peritoneal carcinomatosis of gastric cancer [5,6] has been verified by both experimental [7] and clinical research [5,8].
PubMedID- 21644239 Background: gastric cancer with peritoneal carcinomatosis has a poor prognosis.
PubMedID- 25335714 We investigated the phenotype of macrophages in gastric cancer patients with peritoneal carcinomatosis(pc).
PubMedID- 24530090 Reply to "peritoneal carcinomatosis in patients with gastric cancer and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy".
PubMedID- 20359350 The clinico-pathological progression pattern was very similar to patients of advanced gastric cancer with peritoneal carcinomatosis.
PubMedID- 24997570 Background: treatment of peritoneal carcinomatosis arising from gastric cancer remains a considerable challenge.
PubMedID- 24668709 Objectives: this case report evaluates the feasibility and efficacy of intraperitoneal (ip) trastuzumab administration in gastric cancer (gc) patients with peritoneal carcinomatoses.
PubMedID- 26359244 Paclitaxel (ptx) which easily elutes into ascites is widely used to treat gastric cancer patients with peritoneal carcinomatosis (pc), but clinical outcomes are suboptimal.
PubMedID- 20933363 This review describes the latest surgical treatments for peritoneal carcinomatosis (pc) arising from gastric cancer.
PubMedID- 23369310 Methods: forty-five patients undergoing laparotomy for gastric cancer with peritoneal carcinomatosis were prospectively included from january 2000 to december 2010.
PubMedID- 23021720 peritoneal carcinomatosis arising from gastric cancer is mostly associated with poor prognosis.
PubMedID- 24707431 She was diagnosed with peritoneal carcinomatosis of gastric cancer.
PubMedID- PMC4070603 For the establishment of experimental dosage, the concentration of agp in serum and ascites of gastric cancer patients with peritoneal carcinomatosis (pc) was measured by radial immunodiffusion assay.
PubMedID- 23291656 An in vivo study using a nude mice model of gastric cancer with peritoneal carcinomatosis showed that, compared with free dox, pdox (16 mg/kg, twice that of dox in terms of equal molecular content) produced better antitumor effects in terms of experimental peritoneal carcinomatosis index (epci) (fig.

Page: 1